Ameriprise Financial Inc. lifted its position in Genpact Limited (NYSE:G - Free Report) by 19.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 769,827 shares of the business services provider's stock after purchasing an additional 126,361 shares during the quarter. Ameriprise Financial Inc. owned about 0.44% of Genpact worth $33,064,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in G. Blue Trust Inc. increased its stake in Genpact by 8.7% in the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock valued at $217,000 after acquiring an additional 441 shares during the last quarter. Burney Co. increased its stake in Genpact by 242.8% in the fourth quarter. Burney Co. now owns 130,798 shares of the business services provider's stock valued at $5,618,000 after acquiring an additional 92,641 shares during the last quarter. KBC Group NV bought a new position in Genpact in the fourth quarter valued at $298,000. State of New Jersey Common Pension Fund D bought a new position in Genpact in the fourth quarter valued at $2,030,000. Finally, Pictet Asset Management Holding SA bought a new position in shares of Genpact during the fourth quarter valued at about $921,000. Institutional investors own 96.03% of the company's stock.
Genpact Stock Performance
NYSE:G traded up $0.41 during trading hours on Friday, reaching $44.28. The company had a trading volume of 2,286,869 shares, compared to its average volume of 1,368,521. The firm's 50 day moving average price is $48.02 and its 200-day moving average price is $47.26. The firm has a market cap of $7.74 billion, a price-to-earnings ratio of 15.59, a PEG ratio of 1.84 and a beta of 1.02. Genpact Limited has a 52 week low of $30.38 and a 52 week high of $56.76. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The company had revenue of $1.21 billion for the quarter, compared to analysts' expectations of $1.21 billion. During the same quarter in the previous year, the company earned $0.73 EPS. Genpact's revenue for the quarter was up 7.4% on a year-over-year basis. On average, analysts forecast that Genpact Limited will post 3.21 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on the company. Mizuho raised their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC decreased their target price on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Robert W. Baird decreased their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Genpact presently has a consensus rating of "Hold" and an average price target of $50.71.
View Our Latest Analysis on Genpact
Insider Buying and Selling
In related news, Director Nicholas C. Gangestad bought 2,000 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at $87,940. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by corporate insiders.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.